Belluscura plc announced that three additional U.S. patents have recently issued, increasing the number of issued and pending patent applications the Company owns or exclusively licenses to thirty. The technology covered by the patents, includes: Extracorporeal membrane oxygenation (ECMO) innovations for when people who are very ill with conditions of the heart and lungs, or who are waiting for or recovering from a heart transplant, require a portable artificial lung; Continuous Positive Airway Pressure (CPAP) innovations,a type of non-invasive ventilation (NIV) or breathing support, and; Consumer replaceable molecular sieve technology, used to remove Nitrogen from ordinary air to produce medical grade supplemental oxygen.